NCT01977976

Brief Summary

Implantation failure remains one of the major factors limiting success in IVF treatment. It was postulated that the local injury to endometrium induces secretions of cytokines and growth factors such as leukemia inhibitory factor, interleukin-11, and heparin-binding EGF-like growth factor which enhance decidualisation and facilitate implantation. It may also up-regulate the gene expressions related to endometrial receptivity and optimize the endometrial development. In stimulated cycles, local injury to the proliferative endometrium has been postulated to delay endometrial development thereby inducing synchronicity between endometrium and embryo stage and facilitate implantation (Zhou et al, 2008; Almog et al, 2010; Gnainsky et al, 2010) The aim of the study is to determine whether endometrial injury by endometrial biopsy in mid-secretory phase of the preceding cycle would improve the on-going pregnancy rate in subfertile women undergoing IVF treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2013

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

December 3, 2014

Status Verified

December 1, 2014

Enrollment Period

2.7 years

First QC Date

October 31, 2013

Last Update Submit

December 2, 2014

Conditions

Keywords

Endometrial injuryPipelleImplantationOngoing pregnancy rateIVF

Outcome Measures

Primary Outcomes (1)

  • Ongoing pregnancy rate

    Ongoing pregnancy rate per fresh embryo transfer

    10-12 weeks gestation

Secondary Outcomes (1)

  • implantation rate

    4 weeks after embryo transfer

Other Outcomes (1)

  • Clinical pregnancy rate

    4 weeks after embryo transfer

Study Arms (2)

Endometrial Aspirate (EA) group

EXPERIMENTAL

Endometrial aspirate by pipelle

Procedure: Endometrial aspiration by pipelle

Control group

NO INTERVENTION

No intervention prior to scheduled IVF

Interventions

Endometrial aspiration by pipelle is to be performed on LH+7 in the cycle preceding scheduled IVF treatment

Endometrial Aspirate (EA) group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Undergoing IVF for tubal, unexplained or male factor subfertility
  • Normal uterine cavity as shown on saline sonogram / hysteroscopy done at baseline

You may not qualify if:

  • Presence of hydrosalpinx
  • Presence of endometrial polyp or fibroid distorting uterine cavity
  • IVF cycles carried out for preimplantation genetic diagnosis
  • Use of donor gametes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hong Kong

Hong Kong, Hong Kong

Location

Related Publications (1)

  • Yeung TW, Chai J, Li RH, Lee VC, Ho PC, Ng EH. The effect of endometrial injury on ongoing pregnancy rate in unselected subfertile women undergoing in vitro fertilization: a randomized controlled trial. Hum Reprod. 2014 Nov;29(11):2474-81. doi: 10.1093/humrep/deu213. Epub 2014 Sep 8.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Tracy Yeung, MRCOG

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Consultant

Study Record Dates

First Submitted

October 31, 2013

First Posted

November 7, 2013

Study Start

April 1, 2011

Primary Completion

December 1, 2013

Study Completion

April 1, 2014

Last Updated

December 3, 2014

Record last verified: 2014-12

Locations